DrugScope Latest

New Jan-Feb issue of Druglink out now!

In this issue: In the January-February issue of Druglink we have a focus on 'new drugs' - those substances that have grown in popularity in the last five years such as ketamine, as well as the set of drugs being labelled 'legal highs'. Within this, we have a special two part investigation into mephedrone - a drug that is currently legal but looks set to be outlawed before the election. In addition, there are reports into the harsh treatment handed out to sports stars who are caught taking drugs, how homeless drug users are failed by a divided system and a successful trial of naloxone overdose kits. To find out more, click here

 

Druglink logo

 

 

DrugScope updates

More from Drugscope

If you'd like to sign up for updates about DrugScope's work please click here

 

DrugScope website

subscribe

 

 

DrugScope is pleased to present DS Daily in association with

DDN logo

 

See job vacancies on the DDN site here


 
Thanks to the following sponsors:

 

logo

logo

logo

Concateno logo

Conference consortium logo

 

If you would like to sponsor DS Daily please contact us or call 020 75207550

 

 


Bookmark and Share

 



 

 

 

 

 

Contact us

 

 

Please contact the editor, Jim, or DrugScope at the addresses listed below if you have any queries about the DS Daily service.

 

If you are having difficulties signing up to DS Daily, receiving our emails or any other technical problems with this service please contact Jackie Buckle at jackieb@drugscope.org.uk

 

Jim Young

E: jimy@drugscope.org.uk

 

DrugScope

Suite 204

2nd Floor

109-111 Farringdon Road

London

ECIR 3BW

 

T: 020 7520 7550

F: 020 7520 7555

E: jackieb@drugscope.org.uk

W: www.drugscope.org.uk

 

DrugScope is a registered and independent charity in the UK, number 255030, and a registered company limited by guarantee in England, number 926236.